BioCardia, Inc.
BCDA
$1.83
-$0.04-2.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.75% | 18.83% | 31.33% | 38.36% | 34.21% |
| Total Depreciation and Amortization | -37.66% | -25.93% | -20.24% | -15.29% | -17.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.45% | -17.31% | -22.69% | -25.98% | -20.82% |
| Change in Net Operating Assets | -426.73% | -4,838.89% | -1,043.41% | -435.77% | -70.60% |
| Cash from Operations | -18.94% | 9.28% | 19.53% | 34.32% | 33.68% |
| Capital Expenditure | -33.33% | -200.00% | 50.00% | 64.29% | 89.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -33.33% | -200.00% | 50.00% | 64.29% | 89.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 92.38% | 65.74% | 140.47% | 71.27% | -31.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -113.61% | -105.94% | -89.12% | -133.92% | 1.67% |
| Cash from Financing | 89.73% | 61.18% | 149.60% | 65.09% | -34.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.71% | 100.00% | 120.26% | 164.05% | 33.07% |